Medical Device Information
CooperVision Inc.

CooperVision Inc.

admin202025-09-10 21:44:36

Company Overview

CooperVision Inc., a subsidiary of The Cooper Companies, Inc. (NYSE: COO), is a leading global manufacturer of soft contact lenses. Established in 1980 and incorporated in 1983, CooperVision is headquartered in Pleasanton, California, USA, with production facilities in the UK, USA, and Puerto Rico, and technical support centers in Australia, Spain, and France. Its products are available in over 130 countries, serving a wide range of vision correction needs.

Core Business and Product Pipeline

CooperVision specializes in the research, development, manufacturing, and marketing of contact lenses. Key product lines include:
       Proclear Family: Spherical, toric, and multifocal lenses using PC Technology™ for tear film stability and comfort.
       Biofinity Family: Silicone hydrogel lenses offering high oxygen permeability and comfort.
       MiSight® Daily Disposable: FDA-approved lenses for controlling myopia progression in children.
       MyDay® Silicone Hydrogel Daily Disposable: Comfortable lenses with superior oxygen permeability.
       Avaira®, Frequency®, and Elite® Families: Monthly and multifocal lenses designed for extended wear, premium comfort, and advanced vision correction.

Market Position and Flagship Products

CooperVision ranks among the top three soft contact lens manufacturers globally and is the leading producer of toric lenses. Its flagship products—Proclear, Biofinity, MiSight®, MyDay®, Avaira®, Frequency®, and Elite®—are renowned for innovative materials, advanced lens designs, and exceptional performance. CooperVision's products serve a wide range of vision correction needs, earning trust from eyecare professionals and consumers worldwide.

Research, Innovation, and Sustainability

CooperVision invests heavily in research and development, advancing lens materials, designs, and manufacturing technologies. Collaborating with eyecare professionals and research institutions, it conducts clinical trials, including studies on MiSight® for myopia control. The company also emphasizes sustainability, implementing energy-saving measures, wastewater recycling, and plastic-neutral initiatives to promote a responsible supply chain and ESG compliance.

Financial Performance

In 2024, CooperCompanies Inc. generated $3.63 billion in revenue, with CooperVision contributing $2.14 billion (59% of total). Revenue grew 7% year-on-year, and operating income reached $453 million, a 12% increase. CooperVision manufactures over 2.72 billion contact lenses annually, demonstrating its significant scale and market influence.

Contact Information

Address: 21401 Cabot Boulevard, Pleasanton, California 94588, USA

Keywords: CooperVision Inc., contact lenses, soft contact lenses, toric contact lenses, multifocal contact lenses, myopia control, silicone hydrogel, PC Technology™, vision correction, eyecare

文章下方广告位

猜你喜欢

网友评论